K-HEN Coaching Call 9/4/2012 Update on Adverse Drug Events Donna R. Meador K-HEN Project Director Dolores Hagan K-HEN Education and Data Manager
Agenda 1.Introductions 2.Roll Call and Team Status Reports 3.Data Issues 4.Where we are (K-HEN) re: data and results 5.Guest speaker: Dawn Welch, with HealthCare Excel 6.Q & A
K-HEN ADE Info 13 hospitals committed to project 7 hospitals have entered baseline data (54%) 7 hospitals have entered monitoring data (54%) 1 Progress report submitted 3
ADE Measures K-HEN recommended measures – Outcome: Excessive anticoagulation with warfarin – inpatients, OR Hypoglycemia in patients receiving insulin Process: Inpatient discharge medication reconciliation 4
Aggregated State Data 5
6
ADE Topic-Specific Discussion Update on QIO ADE Activities – Dana Welch, HealthCare Excel 7
Wrap- Up Questions? Thank you for participating! 8